Position in KRYS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$259,794,728
+$93,443,107 QoQ
Shares Held
698,993
+8.5% QoQ
Ownership
2.36%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#10
of 419 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,496,892 across 520 Biotechnology names. KRYS ranks #16 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in KRYS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $259,794,728 | 698,993 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $166,351,621 | 643,975 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $150,852,402 | 611,878 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $107,902,902 | 611,244 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $85,162,929 | 619,547 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $110,407,245 | 612,353 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $92,679,428 | 591,596 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $107,694,590 | 591,631 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $106,551,600 | 580,220 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $93,545,807 | 525,745 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $63,425,178 | 511,246 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $56,055,260 | 483,235 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $52,156,124 | 444,260 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $34,471,514 | 430,571 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $32,648,700 | 412,127 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $27,828,561 | 399,262 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $25,303,722 | 385,375 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $24,306,396 | 365,290 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $23,078,323 | 329,926 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $16,582,313 | 317,608 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $21,771,968 | 320,176 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $22,020,574 | 285,833 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $14,322,420 | 238,707 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $8,994,910 | 208,941 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,469,931 | 180,346 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $7,216,539 | 166,895 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||